Key result
Integrating non-Euclidean geometry into vasa previa screening may improve the precision of risk thresholds.
May refine vasa previa risk thresholds; leaves open clinical utility pending prospective validation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Boujenah et al. (2026) studied this question. Integrating non-Euclidean geometry into vasa previa screening is proposed to improve the precision of risk thresholds.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: